Heart failure is a serious condition in which the heart doesn't pump enough blood throughout the body. It may be caused by several different diseases that damage or overwork the heart muscle; the leading causes include coronary artery disease, high blood pressure and diabetes.
Heart failure is a serious condition in which the heart doesn't pump enough blood throughout the body. It may be caused by several different diseases that damage or overwork the heart muscle; the leading causes include coronary artery disease, high blood pressure and diabetes.
Various drugs used to treat heart failure include:
In general, heart failure patients with left ventricular problems or a history of myocardial infarction should take both an ACE inhibitor and a beta-blocker, and usually a diuretic as well. Angiotensin receptor blockers are recommended for patients who cannot tolerate ACE inhibitors and are sometimes also used as first-line therapy. They also are used for patients who have persistent symptoms and already are treated with an ACE inhibitor plus a beta-blocker.
Most experts believe all ACE inhibitors are effective for treatment of heart failure. Controlled trials have shown that use of bisoprolol, Coreg, or Toprol-XL is consistently associated with a 30% to 40% reduction in the combined end point of mortality and hospitalizations in patients with moderate to severe heart failure.
"There is no published evidence supporting the effectiveness of other beta-blockers for treatment of heart failure," says Mark Abramowicz, MD, editor of The Medical Letter on Drugs and Therapeutics, a non-profit newsletter that critically appraises drugs. "Most experts do not believe that all beta-blockers are equally effective for treatment of heart failure."
ARBS USED FOR HEART FAILURE
Long-term therapy with ARBs reduces the risk of death and other cardiovascular events in patients with heart failure; the results are comparable to ACE inhibitors. The FDA has approved two ARBs for treatment of heart failure: Atacand and Diovan. "Most experts believe that all ARBs could be effective for this indication," says Dr. Abramowicz. "However, the effective dose for other ARBs has not been established by large-scale trials."
Close communication with specially trained nurses can substantially aid heart failure patients and help them control the disease. Alere Medical Inc., of Reno, Nev., offers disease management services for chronic conditions, including heart failure. Under its program, high-risk heart failure patients receive an interactive bathroom scale that can transmit personal data via a phone line. Nurses review the patient's data daily, and when there are signs of trouble, the nurse first telephones the patient to verify the information, and then notifies the doctor via fax.
At their initial assessment and at every subsequent contact, patients are asked about their medications.
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
Upended: Can PBM Transparency Succeed?
March 6th 2024Simmering tensions in the pharmacy benefit management (PBM) industry have turned into fault lines. The PBMs challenging the "big three" have formed a trade association. Purchaser coalitions want change. The head of the industry's trade group says inherent marketplace friction has spilled over into political friction.
Read More
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen
The deliberate disconnection of Change Healthcare to ring fence a cyberattack entered its seventh day today. Prescribers are finding ways to get pharmacy claims processed, and UnitedHealth Group says disruption to the dispensing of prescriptions has been minimal. But independent pharmacies want more information and protection from financial consequences from pharmacy benefit managers.
Read More